PortfoliosLab logoPortfoliosLab logo
LULU vs. REGN
Performance
Return for Risk
Drawdowns
Volatility
Dividends
Financials

Performance

LULU vs. REGN - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Lululemon Athletica Inc. (LULU) and Regeneron Pharmaceuticals, Inc. (REGN). The values are adjusted to include any dividend payments, if applicable.

Loading charts...

Returns By Period

In the year-to-date period, LULU achieves a -43.43% return, which is significantly lower than REGN's -20.58% return. Both investments have delivered pretty close results over the past 10 years, with LULU having a 5.24% annualized return and REGN not far behind at 5.18%.


LULU

1D
2.91%
1M
-10.39%
YTD
-43.43%
6M
-35.78%
1Y
-55.69%
3Y*
-31.16%
5Y*
-18.52%
10Y*
5.24%

REGN

1D
-3.79%
1M
-14.36%
YTD
-20.58%
6M
-12.84%
1Y
24.63%
3Y*
-6.19%
5Y*
3.39%
10Y*
5.18%
*Multi-year figures are annualized to reflect compound growth (CAGR)

LULU vs. REGN - Yearly Performance Comparison


2026 (YTD)202520242023202220212020201920182017
LULU
Lululemon Athletica Inc.
-43.43%-45.66%-25.21%59.59%-18.16%12.48%50.23%90.50%54.74%20.93%
REGN
Regeneron Pharmaceuticals, Inc.
-20.58%8.96%-18.90%21.73%14.25%30.72%28.66%0.53%-0.65%2.42%

Correlation

The correlation between LULU and REGN is 0.13, which is low. Their price movements are largely independent, making them effective diversification partners.


Correlation
Correlation (1Y)
Calculated over the trailing 1-year period

0.13

Correlation (3Y)
Calculated over the trailing 3-year period

0.20

Correlation (5Y)
Calculated over the trailing 5-year period

0.26

Correlation (10Y)
Calculated over the trailing 10-year period

0.24

Correlation (All Time)
Calculated using the full available price history since Jul 30, 2007

0.30

The correlation between LULU and REGN shifts across timeframes, from 0.13 (1 year) to 0.30 (all time), reflecting how their relationship changes across market environments.

Fundamentals

Market Cap

LULU:

$13.57B

REGN:

$65.84B

EPS

LULU:

$12.35

REGN:

$41.05

PE Ratio

LULU:

9.52

REGN:

14.89

PS Ratio

LULU:

1.24

REGN:

4.42

PB Ratio

LULU:

2.70

REGN:

2.10

Total Revenue (TTM)

LULU:

$11.20B

REGN:

$14.92B

Gross Profit (TTM)

LULU:

$6.24B

REGN:

$12.61B

EBITDA (TTM)

LULU:

$2.44B

REGN:

$5.74B

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Return for Risk

LULU vs. REGN — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

LULU
LULU Risk / Return Rank: 22
Overall Rank
LULU Sharpe Ratio Rank: 22
Sharpe Ratio Rank
LULU Sortino Ratio Rank: 33
Sortino Ratio Rank
LULU Omega Ratio Rank: 33
Omega Ratio Rank
LULU Calmar Ratio Rank: 11
Calmar Ratio Rank
LULU Martin Ratio Rank: 22
Martin Ratio Rank

REGN
REGN Risk / Return Rank: 6464
Overall Rank
REGN Sharpe Ratio Rank: 6767
Sharpe Ratio Rank
REGN Sortino Ratio Rank: 6161
Sortino Ratio Rank
REGN Omega Ratio Rank: 6060
Omega Ratio Rank
REGN Calmar Ratio Rank: 6262
Calmar Ratio Rank
REGN Martin Ratio Rank: 6969
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

LULU vs. REGN - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Lululemon Athletica Inc. (LULU) and Regeneron Pharmaceuticals, Inc. (REGN). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


LULUREGNDifference
Sharpe ratioReturn per unit of total volatility

-2.01

Sortino ratioReturn per unit of downside risk

-3.22

Omega ratioGain probability vs. loss probability

0.75

1.16

-0.41

Calmar ratioReturn relative to maximum drawdown

-1.00

0.96

-1.96

Martin ratioReturn relative to average drawdown

-1.73

3.20

-4.92

LULU vs. REGN - Sharpe Ratio Comparison

The current LULU Sharpe Ratio is -1.26, which is lower than the REGN Sharpe Ratio of 0.75. The chart below compares the historical Sharpe Ratios of LULU and REGN, calculated using daily returns over the previous 12 months. A higher Sharpe Ratio indicates better risk-adjusted performance relative to the risk-free rate.


Loading charts...

Sharpe Ratios by Period


LULUREGNDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

-1.26

0.75

-2.01

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

-0.44

0.11

-0.55

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.13

0.16

-0.03

Sharpe Ratio (All Time)

Calculated using the full available price history

0.24

0.16

+0.09

Drawdowns

LULU vs. REGN - Drawdown Comparison

The maximum LULU drawdown since its inception was -92.26%, roughly equal to the maximum REGN drawdown of -91.81%. Use the drawdown chart below to compare losses from any high point for LULU and REGN.


Loading charts...

Drawdown Indicators


LULUREGNDifference

Max Drawdown

Largest peak-to-trough decline

-92.26%

-91.81%

-0.45%

Max Drawdown (1Y)

Largest decline over 1 year

-55.90%

-25.85%

-30.05%

Max Drawdown (3Y)

Largest decline over 3 years

-77.66%

-59.69%

-17.97%

Max Drawdown (5Y)

Largest decline over 5 years

-77.66%

-59.69%

-17.97%

Max Drawdown (10Y)

Largest decline over 10 years

-77.66%

-59.69%

-17.97%

Current Drawdown

Current decline from peak

-77.01%

-48.71%

-28.30%

Average Drawdown

Average peak-to-trough decline

-27.57%

-42.39%

+14.82%

Ulcer Index

Depth and duration of drawdowns from previous peaks

33.71%

7.73%

+25.98%

Volatility

LULU vs. REGN - Volatility Comparison

Lululemon Athletica Inc. (LULU) has a higher volatility of 13.25% compared to Regeneron Pharmaceuticals, Inc. (REGN) at 12.61%. This indicates that LULU's price experiences larger fluctuations and is considered to be riskier than REGN based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


Loading charts...

Volatility by Period


LULUREGNDifference

Volatility (1M)

Calculated over the trailing 1-month period

13.25%

12.61%

+0.64%

Volatility (6M)

Calculated over the trailing 6-month period

32.89%

22.61%

+10.28%

Volatility (1Y)

Calculated over the trailing 1-year period

44.36%

33.09%

+11.27%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

42.19%

30.82%

+11.37%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

40.61%

32.18%

+8.43%

Dividends

LULU vs. REGN - Dividend Comparison

LULU has not paid dividends to shareholders, while REGN's dividend yield for the trailing twelve months is around 0.60%.


PositionTTM2025
LULU
Lululemon Athletica Inc.
0.00%0.00%
REGN
Regeneron Pharmaceuticals, Inc.
0.60%0.46%

Financials

LULU vs. REGN - Financials Comparison

This section allows you to compare key financial metrics between Lululemon Athletica Inc. and Regeneron Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.


Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities


1.00B2.00B3.00B4.00B5.00B20222023202420252026
2.47B
3.61B
(LULU) Total Revenue
(REGN) Total Revenue
Values in USD except per share items

LULU vs. REGN - Profitability Comparison

The chart below illustrates the profitability comparison between Lululemon Athletica Inc. and Regeneron Pharmaceuticals, Inc. over time, highlighting three key metrics: Gross Profit Margin, Operating Margin, and Net Profit Margin.

Gross Margin
Operating Margin
Net Margin
Quarterly
Annual

50.0%60.0%70.0%80.0%90.0%20222023202420252026
54.2%
81.4%
Portfolio components
LULU - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lululemon Athletica Inc. reported a gross profit of 1.34B and revenue of 2.47B. Therefore, the gross margin over that period was 54.2%.

REGN - Gross Margin

Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a gross profit of 2.94B and revenue of 3.61B. Therefore, the gross margin over that period was 81.4%.

LULU - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lululemon Athletica Inc. reported an operating income of 276.95M and revenue of 2.47B, resulting in an operating margin of 11.2%.

REGN - Operating Margin

Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported an operating income of 642.90M and revenue of 3.61B, resulting in an operating margin of 17.8%.

LULU - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lululemon Athletica Inc. reported a net income of 195.05M and revenue of 2.47B, resulting in a net margin of 7.9%.

REGN - Net Margin

Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Regeneron Pharmaceuticals, Inc. reported a net income of 727.20M and revenue of 3.61B, resulting in a net margin of 20.2%.


Frequently Asked Questions


LULU and REGN have a correlation of 0.13, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.

LULU has higher volatility (13.25%) compared to REGN (12.61%). In terms of maximum drawdown, LULU dropped -92.26% vs REGN's -91.81%.

REGN currently has the higher Sharpe Ratio (0.75 vs -1.26), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.

Portfolio Optimizer

Find the right allocation for LULU and REGN

Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.

Open Portfolio Optimizer